University of Milan
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
University of Milan
Oct 10, 2024, 16:44 |
Blog
Giuseppe Curigliano: With T-DXd for HR-Positive Metastatic Breast Cancer
Giuseppe Curigliano shared an article on X: "DESTINY-Breast06 Shows Significant PFS Improvement With T-DXd for HR-Positive…
Oct 10, 2024, 15:57 |
Insight
New ESMO Open editorial on Immunotherapy in breast cancer
ESMO Open shared a recent article by Paola Zagami on X: "Immunotherapy in the treatment landscape…
Oct 7, 2024, 09:18 |
Blog
Dario Trapani: Addressing global challenges in cancer control for 1 community in 1 world at ESMO
Dario Trapani shared a post on X: “Can’t be more grateful to The European Society for Medical…
Sep 13, 2024, 14:38 |
Blog
OncoInfluencers to Follow on Social Media: Dr. Nicola Fusco
We are excited to feature Dr. Nicola Fusco, a distinguished figure in the field of…
Sep 7, 2024, 19:36 |
Insight
A year of treatment with an ADC has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared the following on LinkedIn: “A year of treatment with a medicine…
Aug 29, 2024, 17:23 |
Blog
Common Sense Oncology at ESMO24
Common Sense Oncology posted on X: "Attending ESMO24? Join us on September 13th Friday from…
Aug 17, 2024, 08:43 |
Blog
Dario Trapani: Key actions to tackle current cancer trends toward United Nations SDGs and UHC
Dario Trapani shared ESMO's post, adding: On the latest The European Society for Medical Oncology…
Jul 1, 2024, 18:24 |
Insight
Paolo Tarantino: How long should adjuvant T-DM1 be given for stage I HER2+ eBC?
Paolo Tarantino shared on X: "For how long should adjuvant T-DM1 be given for stage…
Jun 5, 2024, 06:27 |
Blog
Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024
Giuseppe Curigliano shared on LinkedIn: . "Proud to serve on…
May 26, 2024, 06:54 |
Positive
Yvonne Award Winners 2024 by OncoDaily
We are excited to announce the esteemed winners of the Yvonne Award 2024 by OncoDaily, designed…
May 24, 2024, 00:14 |
Insight
Margherita Ambrosini: Rare and important subgroup of POLE/D1 proofreading deficient (pd) mCRC treated with ICIs across Europe, USA and Israel
Margherita Ambrosini, Medical Oncology resident at University of Milan, shared on X/Twitter: "Excited and honored to…
May 11, 2024, 13:18 |
Career
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "We're thrilled to announce the…
Aug 18, 2023, 04:56 |
Insight
Nicola Fusco: The assessment of PDL1 Combined Positive Score (CPS)≥10 in metastatic triple-negative breast cancer.
Nicola Fusco, an Associate Professor at the Department of Oncology and Hemato-Oncology at the University…
All:
13
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube